The Alliance — supported by ample peer-reviewed research, vast professional opinion, and countless patient stories — reaffirms the lifesaving power of colonoscopies.
The Colorectal Cancer Alliance's Walk to End Colon Cancer encourages the general public and people affected by colorectal cancer — the nation’s second deadliest cancer — to pound the pavement against a pervasive silence that puts lives at risk.
Craig Melvin and his wife, Lindsay Czarniak, hosted the inaugural Bottoms Up Invitational to benefit the national nonprofit Colorectal Cancer Alliance.
The Alliance’s Clinical Trial Think Tank seeks to develop patient-centered, systems-level solutions for improving trials and increasing research participation broadly.
The campaign, Op45, encouraged payers to cover colorectal cancer screenings starting at age 45 now. Today, the Alliance applauds every company that has chosen to combat the rise of young-onset CRC through screening before required.
Cross Cycles of Impact a new program from the Colorectal Cancer Alliance and Independence Blue Cross aims to increase awareness and access to preventive colorectal cancer screening through innovative approaches to community engagement and outreach, personalized screening recommendations and treatment for those diagnosed with the disease.
The Alliance launches Blue Hope World, which takes its name from the Alliance’s private Facebook support group Blue Hope Nation, and places an emphasis on raising awareness of colorectal cancer among Meta's Horizon Worlds users, which reportedly number more than 300,000.
Among other awardees, the Colorectal Cancer Alliance received honors and $1,000 for its efforts in colorectal cancer prevention in 2021 from the National Colorectal Cancer Roundtable.
The Colorectal Cancer Alliance is working with Michael’s Mission, a New York-based nonprofit co-founded by Scott Soussa, Shana Auerbach and Allyson Ocean, M.D., to increase colorectal cancer screening rates in New York, New Jersey and Connecticut.
The Colorectal Cancer Alliance announced a transformative research investment strategy to guide the field and its own $30 million in research funding over the next five years.
At Ohio’s Baldwin Wallace and Youngstown State universities, a trio of scholar-athlete siblings will leverage the NCAA’s interim name, image, and likeness rules to increase awareness for colorectal cancer by endorsing the national nonprofit Colorectal Cancer Alliance.
The Blue Hope Bash Denver, now in its fourth year, raises money to fund efforts that can spare others from the pain of losing their loved ones through programs to prevent colorectal cancer, support patients and caregivers, and fund research.
The State of the Science Summit will bring together multidisciplinary experts to collaboratively align on priority areas of research innovation and opportunity for colorectal advancements.
The Colorectal Cancer Alliance announced a major investment by three industry partners to address health inequities in colorectal cancer, specifically among underserved communities who face barriers to access to screening and prevention.
The pandemic forced the cancellation of last year’s Inside Anne’s Closet, the annual fashion show and luncheon fundraiser for the Alliance featuring celebrity and student-athlete models. Founded in 2015, the event honors founding chair John Paye and steering committee chair Amy Paye Venuto’s mother Anne, who had a passion for both fashion and education. Anne died from colorectal cancer in 2013.
The Colorectal Cancer Alliance applauds the United States Preventive Services Task Force for updating its colorectal cancer (CRC) screening guidelines in response to rising cases of CRC in younger adults. The new guidelines state that all people who are at average risk for the disease should begin screening for colorectal cancer at age 45.
Together the Colorectal Cancer Alliance and Perthera will enroll 500 patients in a clinical study to demonstrate the impact of precision oncology on colorectal cancer treatment, with a targeted focus on underserved populations who have lower access to high-quality care.
